Assembly Biosciences (ASMB) Capital Expenditures Growth (3y) (2014 - 2025)
Assembly Biosciences (ASMB) Capital Expenditures Growth (3y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -12.25% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 46.88% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 8.97% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Assembly Biosciences | 282.74 Mn | 56.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.54% |
| Sep 30, 2025 | -37.25% |
| Jun 30, 2024 | -38.09% |
| Mar 31, 2024 | 26.81% |
| Sep 30, 2023 | 34.62% |
| Jun 30, 2023 | -31.15% |
| Dec 31, 2022 | -298.05% |
| Sep 30, 2022 | -62.38% |
| Jun 30, 2022 | -166.25% |
| Mar 31, 2022 | 31.61% |
| Dec 31, 2021 | -55.98% |
| Sep 30, 2021 | 350.24% |
| Jun 30, 2021 | -13.76% |
| Sep 30, 2020 | -74.89% |
| Dec 31, 2019 | -13.16% |
| Sep 30, 2019 | 359.46% |
| Mar 31, 2019 | -821.28% |
| Dec 31, 2018 | 173.89% |
| Jun 30, 2018 | 74.61% |
| Dec 31, 2017 | 40.88% |